Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.32 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.32 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.32 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.32 |
| ▸ | ELANE | P08246 | 1/20 | 0.32 |
| ▸ | FDPS | P14324 | 2/20 | 0.31 |
| ▸ | CES2 | O00748 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.30 |
| ▸ | CPT2 | P23786 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11627695 | 0.98 | LMNA (0.38) | LMNAHSD17B10GAAALDH1A1FFAR3 | |
| SCHEMBL608106 | 0.86 | CA2 (0.36) | HSD17B10ALDH1A1CA1CA2FFAR1 | |
| Ammonia Solution, Strong SCHEMBL29208117 | 0.84 | CA2 (0.35) | HSD17B10ALDH1A1CA1CA2FFAR1 | |
| SCHEMBL608718 | 0.84 | CES2 (0.39) | HSD17B10ALDH1A1CES2FFAR1TDP1 | |
| SCHEMBL25110155 | 0.82 | LMNA (0.34) | LMNAHSD17B10GAAALDH1A1FFAR3 | |
| SCHEMBL5690491 | 0.82 | CES2 (0.42) | HSD17B10ALDH1A1CES2FFAR1TDP1 | |
| SCHEMBL609524 | 0.82 | LMNA (0.40) | LMNAHSD17B10GAAALDH1A1ELANE | |
| SCHEMBL213107 | 0.82 | LMNA (0.40) | LMNAHSD17B10GAAALDH1A1ELANE | |
| SCHEMBL31094249 | 0.82 | LMNA (0.35) | LMNAHSD17B10 | |
| SCHEMBL213108 | 0.81 | LMNA (0.36) | LMNAHSD17B10GAAALDH1A1ELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 165 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12463253-B2 | Nonaqueous electrolyte solution secondary battery | GS YUASA INTERNATIONAL LTD. (JP) | 2025-11-04 | — | — | US | disclosed |
| US-20250233206-A1 | NON-AQUEOUS ELECTROLYTE SOLUTION AND NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY EMPLOYING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-07-17 | — | — | US | disclosed |
| US-12315883-B2 | Non-aqueous electrolyte solution and non-aqueous electrolyte secondary battery employing the same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-05-27 | — | — | US | disclosed |
| US-12261265-B2 | Method for producing lithium fluorosulfonate, lithium fluorosulfonate, nonaqueous electrolytic solution, and nonaqueous electrolytic solution secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-03-25 | — | — | US | disclosed |
| CN-118156613-A | Electrolyte additive for lithium ion or sodium ion secondary battery and application thereof | 北京大学深圳研究生院 | 2024-06-07 | — | — | CN | disclosed |
| US-20230395857-A1 | NON-AQUEOUS ELECTROLYTE SOLUTION AND NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY EMPLOYING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2023-12-07 | — | — | US | disclosed |
| US-11791499-B2 | Non-aqueous electrolyte solution and non-aqueous electrolyte secondary battery employing the same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2023-10-17 | — | — | US | disclosed |
| EP-4219400-A2 | METHOD FOR PRODUCING LITHIUM FLUOROSULFONATE, LITHIUM FLUOROSULFONATE, USE OF LITHIUM FLUOROSULFONATE IN A NONAQUEOUS ELECTROLYTIC SOLUTION, AND NONAQUEOUS ELECTROLYTIC SOLUTION | Mitsubishi Chemical Corporation (JP) | 2023-08-02 | — | — | EP | disclosed |
| EP-3528330-B1 | NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEM CORP (JP) | 2023-07-26 | — | — | EP | disclosed |
| US-11695155-B2 | Non-aqueous electrolytic solution and non-aqueous electrolyte secondary battery using the same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2023-07-04 | — | — | US | disclosed |
| EP-0666254-A1 | 2-Aroylcydohexanediones, process for their preparation and their use as herbicide or as plant growth regulating agent | BASF AKTIENGESELLSCHAFT (DE) | 1995-08-09 | — | — | EP | disclosed |
| EP-0655995-A1 | CYCLOHEXENONOXIME ETHERS, THEIR PREPARATION AND THEIR USE | BASF Aktiengesellschaft (DE) | 1995-06-07 | — | — | EP | disclosed |
| EP-0625975-A1 | CYCLOHEXENONE OXIME ETHERS, PROCESS FOR MAKING THEM AND THEIR USE AS HERBICIDES. | BASF AG (DE) | 1994-11-30 | — | — | EP | disclosed |
| EP-0625974-A1 | MIXTURES OF OPTICALLY ACTIVE CYCLOHEXENONE OXIME ETHERS, PROCESS AND INTERMEDIATE PRODUCTS FOR THEIR PRODUCTION AND THEIR USE AS HERBICIDES | BASF Aktiengesellschaft (DE) | 1994-11-30 | — | — | EP | disclosed |
| EP-0600717-A1 | Phenoxyalkylamines, -pyrrolidines and -piperidines for the treatment and prevention of circulatory diseases and psychosis | SANKYO COMPANY LIMITED (JP) | 1994-06-08 | — | — | EP | disclosed |
| WO-1994004489-A1 | CYCLOHEXENONOXIME ETHERS, THEIR PREPARATION AND THEIR USE | BASF AKTIENGESELLSCHAFT (DE) | 1994-03-03 | — | — | WO | disclosed |
| WO-1993016062-A1 | MIXTURES OF OPTICALLY ACTIVE CYCLOHEXENONE OXIME ETHERS, PROCESS AND INTERMEDIATE PRODUCTS FOR THEIR PRODUCTION AND THEIR USE AS HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1993-08-19 | — | — | WO | disclosed |
| WO-1993016063-A1 | CYCLOHEXENONE OXIME ETHERS, PROCESS FOR MAKING THEM AND THEIR USE AS HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1993-08-19 | — | — | WO | disclosed |
| WO-1993011669-A1 | USE OF 3-PHENYLURACIL DERIVATIVES FOR THE DESICCATION AND ABSCISSION OF PLANT PARTS | BASF AKTIENGESELLSCHAFT (DE) | 1993-06-24 | — | — | WO | disclosed |
| US-4067726-A | 3-Ureido phenylacetamide herbicides | BAYER AKTIENGESELLSCHAFT (DT) | 1978-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11695155-B2 | Non-aqueous electrolytic solution and non-aqueous electrolyte secondary battery using the same | PTPN1, TP53RK, VDAC1 | LMNA 3940/4885HSD17B10 1903/4885GAA 3551/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.